Publicaciones - IR Sant Pau

Buscar

01/05/2026 Ventricular free-wall rupture, ventricular pseudoaneurysm, and papillary muscle rupture complicating acute myocardial infarction: A clinical consensus statement of the ESC Working Group on Cardiovascular Surgery, the Association for Acute CardioVascular Care of the ESC, the European Association of Percutaneous Cardiovascular Interventions of the ESC, the ESC Working Group on Pulmonary Circulation and Right Ventricular Function, the European Association of Preventive Cardiology of the ESC, the Heart Failure Association of the ESC, the European Association of Cardiovascular Imaging of the ESC, and the European Association for Cardio-Thoracic Surgery

Lorusso, R, Matteucci, M, Ronco, D, Massimi, G, Price, S, Czerny, M, Estévez-Loureiro, R, Siepe, M, Pontone, G, Hassager, C, Chioncel, O, Zuin, M, Davos, CH, Adamo, M, Gustafsson, F, Giannakoulas, G, Amabile, N, Sionis, A, Thielmann, M, Petersen, SE, Cosyns, B, Huber, K, Tokmakova, M, Pacini, D, Klok, FA, Saia, F, Abreu, A, Grimm, M, Claeys, MJ, García-Alvarez, A, Gerber, B, Mestres, CA, Rosenkranz, S, Adamopoulos, S, Bonaros, N. Ventricular free-wall rupture, ventricular pseudoaneurysm, and papillary muscle rupture complicating acute myocardial infarction: A clinical consensus statement of the ESC Working Group on Cardiovascular Surgery, the Association for Acute CardioVascular Care of the ESC, the European Association of Percutaneous Cardiovascular Interventions of the ESC, the ESC Working Group on Pulmonary Circulation and Right Ventricular Function, the European Association of Preventive Cardiology of the ESC, the Heart Failure Association of the ESC, the European Association of Cardiovascular Imaging of the ESC, and the European Association for Cardio-Thoracic Surgery. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY. 2026; 68(5)DOI:10.1093/ejcts/ezag157. PMID:42112794. IF:3.000(Q1/2D).

01/05/2026 EOSINOPHILIC MYOCARDITIS INTERNATIONAL REGISTRY

Palazzini, M, Lehtonen, J, Potena, L, Mäyränpää, M, Rågback, J, Foà, A, Uribarri, A, Thiele, H, Vidal-burdeus, M, Freund, A, Gustafsson, F, Tschöpe, C, Elsanhoury, A, Ihle, J, Rudi, W, Grabmaier, U, Merlo, M, Melenovsky, V, Weislova, I, Jellinghaus, S, Linke, A, Baldovini, C, Adorisio, R, Kuchynka, P, Palecek, T, Krejcí, J, Poloczková, H, Caterino, A, Gilotra, N, Lovell, J, Macomb, E, Shih, J, Hong, K, Rossi, V, Ruschitzka, F, Cavallini, C, Riccini, C, Kamal, M, Huang, F, Groh, M, Gentile, P, Andrea, G, Lala, A, Shimokawa, H, Vandenbriele, C, Sionis, A, Schmidt, M, Grosu, A, Bollano, E, Turco, A. EOSINOPHILIC MYOCARDITIS INTERNATIONAL REGISTRY. EUROPEAN HEART JOURNAL SUPPLEMENTS. 2026; 28DOI:10.1093/eurheartjsupp/suag058.401. PMID:. IF:2.500(Q2/5D).

01/05/2026 Differential regulation of the HIF-1«/apoptosis axis by miR-126-5p in cardiac cells during ischemia/reperfusion injury

Ramos-Regaladoa, L, Schoch, L, Alcovera, S, Magaldi, M, Barriusoa, I, Padróa, T, Borrella, M, Badimona, L, Zaragozad, C, Vilahura, G. Differential regulation of the HIF-1«/apoptosis axis by miR-126-5p in cardiac cells during ischemia/reperfusion injury. Clinica E Investigacion En Arteriosclerosis. 2026; 38(3)DOI:10.1016/j.arteri.2025.500842. PMID:40816967. IF:(Q/D).

01/05/2026 Effect of type-2 diabetes on surface lipids and biophysical properties in lipoprotein populations

Reis, A, Araújo, ARD, Dias, IH, Antonny, B, Perez, A, Sánchez-Quesada, JL, de Freitas, V. Effect of type-2 diabetes on surface lipids and biophysical properties in lipoprotein populations. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS. 2026; 779DOI:10.1016/j.abb.2026.110780. PMID:41780664. IF:3.000(Q2/4D).

01/05/2026 Mechanisms of damage and therapies for cardiac amyloidosis: a role for inflammation?

Bellofatto, IA, Nikolaou, PE, Andreadou, I, Canepa, M, Carbone, F, Ghigo, A, Heusch, G, Kleinbongard, P, Maack, C, Podesser, BK, Stamatelopoulos, K, Stellos, K, Vilahur, G, Montecucco, F, Liberale, L. Mechanisms of damage and therapies for cardiac amyloidosis: a role for inflammation?. Clinical Research in Cardiology. 2026; 115(5)DOI:10.1007/s00392-024-02522-2. PMID:39167195. IF:3.700(Q1/3D).

01/05/2026 A five-year risk prediction model of cardiovascular disease in individuals with bipolar disorder: a nationwide register study from Sweden

Dobrosavljevic, M, Landén, M, Brikell, I, Chang, Z, Kuja-Halkola, R, Lichtenstein, P, Andell, P, Andreassen, OA, Bauer, M, Corcoy, R, De Girolamo, G, Reif, A, Larsson, H, Garcia-Argibay, M. A five-year risk prediction model of cardiovascular disease in individuals with bipolar disorder: a nationwide register study from Sweden. MOLECULAR PSYCHIATRY. 2026; 31(5)DOI:10.1038/s41380-025-03381-7. PMID:41420114. IF:10.100(Q1/1D).

01/05/2026 Lipid prevention in type 1 diabetes: From estimated risk to cumulative risk

Miñambres, I, Pérez, A. Lipid prevention in type 1 diabetes: From estimated risk to cumulative risk. Clinica E Investigacion En Arteriosclerosis. 2026; 38(3)DOI:10.1016/j.arteri.2026.500894. PMID:41690856. IF:(Q/D).

01/05/2026 Prevalence of germline variants in USP8, USP48, CABLES1 and PAM in patients with pituitary adenomas

de Lapiscina, IM, Baquero, C, Santos, A, Molina, AR, Moure, MD, Aramburu, M, Bancalari, R, Boronat, M, Bueno, G, Casano-Sancho, P, Fernandez-Ramos, C, Garcia-Garcia, E, Gonzalez, A, Gonzalez-Rivera, N, Guerrero-Fernandez, J, Hernandez, MI, Paja, M, Portillo, N, Rica, I, Soto-Moreno, A, Suarez-Ortega, L, Vela, A, Castaño, L, Valdes, N. Prevalence of germline variants in USP8, USP48, CABLES1 and PAM in patients with pituitary adenomas. EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2026; 194(5)DOI:10.1093/ejendo/lvag074. PMID:42045809. IF:5.200(Q1/2D).

01/05/2026 Effects of zibotentan and dapagliflozin combined in patients with compensated cirrhosis: A randomized placebo-controlled exploratory study

Garcia-Pagan, JC, Gluud, LL, Mandorfer, M, Schattenberg, JM, De Gottardi, A, Berzigotti, A, Fortea, JI, Martínez, AA, Alvarado-Tapias, E, Berning, M, Petryszyn, P, Henricson, E, Berglind, N, Lin, M, Persson, K, Mercier, A, Ambery, P, Bosch, J, Oscarsson, J, Rockey, DC. Effects of zibotentan and dapagliflozin combined in patients with compensated cirrhosis: A randomized placebo-controlled exploratory study. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2026; 92(5)DOI:10.1002/bcp.70332. PMID:41362018. IF:3.000(Q2/4D).

01/05/2026 Antithrombotic and management of small bowel bleeding - time to throw caution into the wind?

Scaramella, L, Cosenza, A, Romero-Mascarell, C, Elli, L. Antithrombotic and management of small bowel bleeding - time to throw caution into the wind?. CURRENT OPINION IN GASTROENTEROLOGY. 2026; 42(3)DOI:10.1097/MOG.0000000000001160. PMID:41700996. IF:2.500(Q2/5D).

01/05/2026 Baseline and 4-year associations between prediabetes and kidney impairment: Insights from the ILERVAS cohort

Izarra, A, Bermúdez-López, M, Valdivielso, JM, Pamplona, R, Torres, G, Mauricio, D, Castro-Boqué, E, Fernández, E, Simó, R, Hernández, C, Lecube, A. Baseline and 4-year associations between prediabetes and kidney impairment: Insights from the ILERVAS cohort. DIABETES OBESITY & METABOLISM. 2026; 28(5)DOI:10.1111/dom.70560. PMID:41705635. IF:5.700(Q1/2D).

01/05/2026 Consensus definition of stage III non-small-cell lung cancer technical resectability to standardise inclusion criteria for clinical trials: a multisocietal EORTC-Lung Cancer Group collaboration

Dingemans, AMC, Opitz, I, Brunelli, A, Remon, J, Hendriks, LE, Edwards, J, Faivre-Finn, C, Reguart, N, Smit, EF, Levy, A, Sanchez-Lorente, D, Trujillo, JC, Filippi, AR, Stathopoulos, K, Blum, TG, Guckenberger, M, Popat, S, De Angelis, R, Hofman, P, von der Thüsen, J, Hartemink, KJ, Petersen, RH, Ruffini, E, Dickhoff, C, Houda, I, Prisciandaro, E, De Ruysscher, D, Derks, J, Bahce, I, Mariolo, A, Besse, B, Xenophontos, E, Levra, NG, van Schil, P, Brandao, M, Berghmans, T. Consensus definition of stage III non-small-cell lung cancer technical resectability to standardise inclusion criteria for clinical trials: a multisocietal EORTC-Lung Cancer Group collaboration. Lancet Respiratory Medicine. 2026; 14(5)DOI:10.1016/S2213-2600(26)00051-2. PMID:41895314. IF:32.800(Q1/1D).

01/05/2026 Characterizing early behavioral and social-emotional problems in young children with SCN1A+Dravet syndrome: Findings from the ENVISION prospective natural history study

Scheffer, IE, Perry, MS, Sullivan, J, Boronat, S, Wheless, J, Brunklaus, A, Laux, L, Patel, AD, Roberts, C, Dlugos, D, Holder, D, Knupp, K, Lallas, M, Phillips, S, Segal, E, Lal, D, Wirrell, E, Zuberi, SM, Shaffer, R, Wojnaroski, M, Berl, MM, Christensen, S, James, ES, Vila, MC, Huang, N, Gofshteyn, JS, Rico, S. Characterizing early behavioral and social-emotional problems in young children with SCN1A+Dravet syndrome: Findings from the ENVISION prospective natural history study. EPILEPSIA. 2026; 67(5)DOI:10.1002/epi.70127. PMID:41627953. IF:6.600(Q1/1D).

01/05/2026 Ultrastructural analysis of transjugular biopsies in metabolic dysfunction-associated steatotic liver disease identifies core hepatocellular stress adaptations

Ibañez-Samaniego, L, Alonso, S, Cagigal, ML, Catalina, MV, Rodriguez, DR, Peligros, MI, Puente, A, Collado, AS, Téllez, L, Herrera, EL, Alvarado-Tapias, E, Iruzubieta, P, Loste, MTA, Fabrega, E, Cuadrado, A, Lafarga, M, Fortea, J. Ultrastructural analysis of transjugular biopsies in metabolic dysfunction-associated steatotic liver disease identifies core hepatocellular stress adaptations. JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).

01/05/2026 Glucagon-like peptide-1 receptor agonists reduce the risk of decompensation in patients with type 2 diabetes across different stages of liver disease

Fajol, MC, Brujats, A, Poca, M, Villanueva, C, Bataller, R, Gomariz, V, Ferrero, A, Alvarado-Tapias, E. Glucagon-like peptide-1 receptor agonists reduce the risk of decompensation in patients with type 2 diabetes across different stages of liver disease. JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).

01/05/2026 Long-term outcomes of compensated cirrhosis with mild portal hypertension

Huerta, A, Brujats, A, Alvarado-Tapias, E, Pons, M, Téllez, L, Ojeda, A, Aracil, C, Amezcua, AG, Torres, F, Garcia-Pagán, JC, Albillos, A, Genesca, J, Escorsell, A, Bosch, J, Villanueva, C. Long-term outcomes of compensated cirrhosis with mild portal hypertension. JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).

01/05/2026 Myeloid-specific ST6Gal1 deficiency favours atherosclerotic progression

Galvez, CM, Blanco-Colio, L, Picatoste, B, Ortega-Villanueva, L, Mendez-Barbero, N, Oller-Pedrosa, J, Escola-Gil, JC, Bellis, S, Rabinovich, G, Martin-Ventura, JL. Myeloid-specific ST6Gal1 deficiency favours atherosclerotic progression. CARDIOVASCULAR RESEARCH. 2026; 122DOI:10.1093/cvr/cvag092.157. PMID:. IF:13.300(Q1/1D).

01/05/2026 Sex Differences in Cardiac Involvement in Adults With Myotonic Dystrophy Type 1 A Multicenter Study

Alen, A, Muñoz, C, Soriano-Amores, M, de Frutos, F, Báez-Ferrer, N, Peña-Peña, ML, Villacorta, E, Ripoll-Vera, T, Zorio, E, Martínez-Gimeno, A, Bermúdez-Jiménez, J, Limeres, J, Tiron, C, Martínez-Alvarez, E, Cabrera-Romero, E, García-Pavía, P, Espinosa, MA, Piqueras, J, García-Hernández, S, Palomino-Doza, J, Moliner-Abós, C, Moris, G, Carrillo-Mora, LM, Syrris, P, Alvarez-Velasco, R, Gimeno, JR, Lorca, R. Sex Differences in Cardiac Involvement in Adults With Myotonic Dystrophy Type 1 A Multicenter Study. JACC-ADVANCES. 2026; 5(5)DOI:10.1016/j.jacadv.2026.102771. PMID:42202377. IF:(Q/D).

01/05/2026 HDL structural and compositional alterations in type 2 diabetes mellitus patients: identifying potential biomarkers for subclinical atherosclerosis detection and disease progression

Martinez, GG, Padro, T, Guala, A, Fernandez, R, Garcia-Elias, A, Borrell-Pages, M, Olivero, R, Martin-Grieve, S, Badimon, L, Maceira, A, Rodriguez-Palomares, JF, Vilahur, G. HDL structural and compositional alterations in type 2 diabetes mellitus patients: identifying potential biomarkers for subclinical atherosclerosis detection and disease progression. CARDIOVASCULAR RESEARCH. 2026; 122DOI:10.1093/cvr/cvag092.071. PMID:. IF:13.300(Q1/1D).

01/05/2026 MicroRNA changes in plasma associated with fibrous coronary plaque remodelling after PCSK9 inhibitor therapy in familial hypercholesterolemia with subclinical atherosclerosis

Chavez, REE, De Isla, LPP, Casanas, MC, Romero, MJR, Badimon, LB, Vilahur, GV, Mata, PM, Padro, TP. MicroRNA changes in plasma associated with fibrous coronary plaque remodelling after PCSK9 inhibitor therapy in familial hypercholesterolemia with subclinical atherosclerosis. CARDIOVASCULAR RESEARCH. 2026; 122DOI:10.1093/cvr/cvag092.002. PMID:. IF:13.300(Q1/1D).

01/05/2026 Long-term tissue factor expression orchestrates the angiogenic potential of adipose derived stem cells through par smad signaling and activin a cooperation

Urgell, AC, Garcia, O, Pena, E, Vilahur, G, Marques, GA. Long-term tissue factor expression orchestrates the angiogenic potential of adipose derived stem cells through par smad signaling and activin a cooperation. CARDIOVASCULAR RESEARCH. 2026; 122DOI:10.1093/cvr/cvag092.136. PMID:. IF:13.300(Q1/1D).

01/05/2026 In Memoriam: Glen F. PhD

Dababneh, SF, Claydon, TW, Shafaattalab, S, Prondzynski, M, Kashihara, H, Hove-Madsen, L, Sanatani, S. In Memoriam: Glen F. PhD. CANADIAN JOURNAL OF CARDIOLOGY. 2026; 42(5)DOI:10.1016/j.cjca.2026.03.002. PMID:41796860. IF:5.300(Q1/2D).

01/05/2026 Multidisciplinary clinical practice guideline on the management of metabolic hepatic steatosis (vol 48, 502442. 2025)

Romero-Gómez, M, Escalada, J, Noguerol, M, Pérez, A, Carretero, J, Crespo, J, Mascort, JJ, Aguilar, I, Tinahone, F, Cañones, P, Gómez-Huelgas, R, de Luis, D, Trullos, IG, Aller, R, Rubio, MA, Calleja, JL. Multidisciplinary clinical practice guideline on the management of metabolic hepatic steatosis (vol 48, 502442. 2025). Gastroenterologia y Hepatologia. 2026; 49(5)DOI:10.1016/j.gastrohep.2025.502639. PMID:41571546. IF:1.900(Q3/7D).

01/05/2026 Liver fibrosis is the only predictor of adverse outcomes: time to remove metabolic dysfunction associated steatohepatitis (MASH) resolution as a clinical trial endpoint

Younossi, ZM, Yu, ML, de Avila, L, Petta, S, Hagström, H, Kim, SU, Nakajima, A, Crespo, J, Castera, L, Alkhouri, N, Zheng, MH, Treeprasertsuk, S, Ananchuensook, P, Shalimar, S, Tsochatzis, E, Shenoy, KT, Mohan, L, Fan, JG, Roberts, S, Alswat, KA, Wong, VWS, Yilmaz, Y, Dunn, W, Francque, S, Cordie, A, Alqahtani, S, Ekstedt, M, Goh, GBB, Oliveira, CP, Pessoa, M, Chan, WK, Fernández, MIC, Duseja, AK, Arab, JP, Papatheodoridis, G, Sebastiani, G, Villela-Nogueira, CA, D'Ambrosio, R, Lampertico, P, Al Naamani, K, Holleboom, AG, Valsan, A, Venu, A, El-Kassas, M, Pennisi, G, Shang, Y, Liu, WY, Lee, HW, Kobayashi, T, Kakizaki, S, Caussy, C, Pearlman, B, Iruzubieta, P, Nadeem, R, Cinque, F, Papatheodoridi, M, Zoncape, M, Yang, RX, Song, SJ, Dunn, N, Gadi, Z, Yeh, ML, Teh, KKJ, Mahadeva, S, Fabian, LG, Almohsen, A, Leite, N, Pugliese, N, Vessby, J, Xie, CC, Choudhary, NS, Friend, E, Poca, M, Kawaguchi, T, Russo, FP, Gadano, A, Diaz, LA, Singal, AK, Ségrestin, B, Gunn, N, Mauricio, D, Arrese, M, Fracanzani, AL, Lombardi, R, Aghemo, A, Zelber-Sagi, S, Lam, B, Racila, A, Stepanova, M. Liver fibrosis is the only predictor of adverse outcomes: time to remove metabolic dysfunction associated steatohepatitis (MASH) resolution as a clinical trial endpoint. JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).

01/05/2026 Clinical significance of patients with significant fibrosis missed by the EASL algorithm in metabolic-associated steatotic liver disease: findings from the HEPAMET registry

Ampuero, J, Crespo, J, Maya-Miles, D, Ibañez-Samaniego, L, Panero, JLC, Graupera, I, Jiménez-Massip, A, Aller, R, Gómez-Camarero, J, Benlloch, S, Martin-Mateos, R, Morillas, RM, Gallego-Durán, R, Bernal, V, Turnes, J, Sanchez, MD, Poca, M, Martínez, RL, Escudero-García, D, Lo Iacono, O, Olveira, A, Francés, R, Iruzubieta, P, Lopez, LS, Esteban, JR, Soria, A, Pericàs, JM, Romero-Gómez, M. Clinical significance of patients with significant fibrosis missed by the EASL algorithm in metabolic-associated steatotic liver disease: findings from the HEPAMET registry. JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).

01/05/2026 The body roundness index as a novel anthropometric marker in metabolic-associated steatotic liver disease: findings from the HEPAMET registry

Maya-Miles, D, Aller, R, Crespo, J, Ibañez-Samaniego, L, González, A, Pericàs, JM, Sanchez, MD, Escudero-Garcia, D, Rosales-Zábal, JM, Benlloch, S, Gómez-Camarero, J, Diez, R, Pavon-Castillero, E, Graupera, I, Latorre, R, Morillas, RM, Panero, JLC, Turnes, J, Aspichueta, P, Gallego-Durán, R, Francés, R, Martin-Mateos, R, Bernal, V, Poca, M, Olveira, A, Rodriguez, CF, Andrade, RJ, Carnicero, C, Iruzubieta, P, Lopez, LS, Fuertes-Yebra, E, Jiménez-Massip, A, Romero-Gómez, M, Ampuero, J. The body roundness index as a novel anthropometric marker in metabolic-associated steatotic liver disease: findings from the HEPAMET registry. JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).

01/05/2026 Optimizing hepatocellular cancer surveillance in metabolic dysfunction-associated steatotic liver disease based on liver stiffness measurement

Bertot, LC, Roberts, S, Ampuero, J, Crespo, J, Iruzubieta, P, Maya-Miles, D, Carrillo-Fernández, P, Kemp, W, Mohamedashrafali, MAAC, Teoh, B, Ibañez-Samaniego, L, Lopez, LS, Sigüenza, R, Arroyo-López, V, Esteban, JR, Guerra, JA, Romero-Gómez, M, Camarero, JG, Albillos, A, Poca, M, Andrade, RJ, Ortiz, JPT, Sanchez, MD, George, J, Wallace, M, Aller, R, Adams, L. Optimizing hepatocellular cancer surveillance in metabolic dysfunction-associated steatotic liver disease based on liver stiffness measurement. JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).

01/05/2026 Social determinants of health are associated with the risk of hepatic and cardiovascular events in patients with advanced MASLD: prediction using the novel LiverSocial score

Lázaro, DR, Jiménez-Massip, A, El Maimouni, C, Canillas, L, Vergara, M, Poca, M, Rodríguez-Castellano, A, Munoz, EE, Serra, I, Pagès, L, Carrión, J, Soria, A, Mas, E, Morillas, RM, Ginès, P, Graupera, I, Broquetas, T, Pericàs, JM. Social determinants of health are associated with the risk of hepatic and cardiovascular events in patients with advanced MASLD: prediction using the novel LiverSocial score. JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).

01/05/2026 Healthcare provider perspectives on mental health in metabolic dysfunction-associated steatotic liver disease and steatohepatitis: the role of multidisciplinary teams and sex differences

Ivancovsky-Wajcman, D, Villota-Rivas, M, Manolas, M, Villas-Riotorto, V, Arora, A, Brennan, PN, Mauricio, D, Leith, D, Willemse, J, Betel, M, Alnaser, F, El Kassas, M, Lazarus, J. Healthcare provider perspectives on mental health in metabolic dysfunction-associated steatotic liver disease and steatohepatitis: the role of multidisciplinary teams and sex differences. JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).

01/05/2026 Factors influencing mental health care provision for people with metabolic dysfunction-associated steatotic liver disease and steatohepatitis

Ivancovsky-Wajcman, D, Villota-Rivas, M, Manolas, M, Villas-Riotorto, V, Arora, A, Brennan, PN, Mauricio, D, Leith, D, Willemse, J, Betel, M, Alnaser, F, El Kassas, M, Lazarus, J. Factors influencing mental health care provision for people with metabolic dysfunction-associated steatotic liver disease and steatohepatitis. JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).

01/05/2026 Multidisciplinary clinical practice guidelines for the management of metabolic fatty liver disease

Romero-Gómez, M, Escalada, J, Noguerol, M, Pérez, A, Carretero, J, Crespo, J, Mascort, JJ, Aguilar, I, Tinahones, F, Cañones, P, Gómez-Huelgas, R, de Luis, D, Trullos, IG, Aller, R, Rubio, MA, Calleja, JL. Multidisciplinary clinical practice guidelines for the management of metabolic fatty liver disease. Gastroenterologia y Hepatologia. 2026; 49(5)DOI:10.1016/j.gastrohep.2025.502640. PMID:. IF:1.900(Q3/7D).

01/05/2026 Association of Metabolic Dysfunction-Associated Steatohepatitis with Metabolic-Related Diseases Diabetes, Prediabetes, and Obesity

Diamantopoulos, L, Kalligeros, M, Isaacs, SD, Mauricio, D. Association of Metabolic Dysfunction-Associated Steatohepatitis with Metabolic-Related Diseases Diabetes, Prediabetes, and Obesity. Clinics in Liver Disease. 2026; 30(2)DOI:10.1016/j.cld.2025.12.001. PMID:42142893. IF:4.100(Q1/3D).

01/05/2026 The echo of a question, ten years later: Letter to Amanda and Jesus

Milad, C, Mesa, A. The echo of a question, ten years later: Letter to Amanda and Jesus. Endocrinologia Diabetes y Nutricion. 2026; 73(5)DOI:10.1016/j.endien.2026.501772. PMID:41887969. IF:1.800(Q3/8D).

01/05/2026 Serological responses COVID-19 vaccination: a potential biomarker to predict liver-related complications in patients with compensated advanced liver disease (cACLD)

Hong, CZ, Ballester, MP, Perricone, G, Merli, M, Buti, M, Panero, JLC, Soriano, G, Toniutto, P, Ampuero, J, Russo, FP, Sacerdoti, D, Coenraad, M, Berenguer, M, Piano, S, Sangiovanni, A, Albillos, A, Gander, A, Patel, VC, Caraceni, P, Wright, G, Iruzubieta, P, Andrade, RJ, Garcia-Samaniego, FJ, Verhelst, X, Uson, E, Sanchez-Garrido, C, Mehta, G, Jalan, R. Serological responses COVID-19 vaccination: a potential biomarker to predict liver-related complications in patients with compensated advanced liver disease (cACLD). JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).

01/05/2026 Assessment of cardiometabolic comorbidities and the impact of glycemic and weight control on liver stiffness in advanced metabolic dysfunction-associated steatotic liver disease

El Maimouni, C, Jiménez-Massip, A, Canillas, L, Serra, I, Vergara, M, Morillas, RM, Poca, M, Broquetas, T, Rodríguez-Castellano, A, Munoz, EE, Soria, A, Pages, L, Carrión, J, Casas, M, Ardevol, A, Rojo, D, Alonso, N, Julián, MT, Bassegoda, O, Gines, P, Pericàs, JM, Graupera, I. Assessment of cardiometabolic comorbidities and the impact of glycemic and weight control on liver stiffness in advanced metabolic dysfunction-associated steatotic liver disease. JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).

01/05/2026 Treatment with albumin improves circulatory function in patients with cirrhosis and hypovolemic hyponatremia: insights from a randomized controlled trial, the ALBUCAT study

Juanola, A, Moreta, MJ, Solé, C, Perez-Guasch, M, Gratacós-Ginès, J, Soria, A, Cuyàs, B, Martin-Llahi, M, Ma, A, Pompili, E, Fernández, I, Amorós, M, Cruceta, A, Diestro, S, Domenech, G, Rios, J, Sánchez, J, Fabrellas, N, Graupera, I, Pose, E, Ginès, P. Treatment with albumin improves circulatory function in patients with cirrhosis and hypovolemic hyponatremia: insights from a randomized controlled trial, the ALBUCAT study. JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).

01/05/2026 Efficacy and safety of endoscopic and endovascular interventions for secondary prophylaxis of gastric varices in patients with cirrhosis: systematic review and individual patient data meta-analysis

Biswas, S, Aggarwal, A, Lo, GH, Luo, XF, Yang, L, Escorsell, A, Mehta, S, Swaroop, S, Agarwal, S, Agarwal, A, Mishra, A, Tripathi, S, Gunjan, D, Gamangatti, S, Shalimar. Efficacy and safety of endoscopic and endovascular interventions for secondary prophylaxis of gastric varices in patients with cirrhosis: systematic review and individual patient data meta-analysis. JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).

01/05/2026 Predictive model of postoperative mortality in patients with cirrhosis. Surgical risk score for patients with cirrhosis (S-RISC)

Canillas, L, Jimenez-Esquivel, N, Amador, A, Brujats, A, Sánchez, J, Pelegrina, A, Pardo, C, Montaña, SH, Fajol, MC, de Sárraga, C, Alvarez, J, Duran, X, Burdio, F, Reverter, E, Carrión, JA. Predictive model of postoperative mortality in patients with cirrhosis. Surgical risk score for patients with cirrhosis (S-RISC). JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).

01/05/2026 SIRT5 rs12216101 T > G variant is associated with hepatic encephalopathy and impaired ammonia metabolism in patients with cirrhosis

Salomone, F, Gil-Gómez, A, Barreca, F, Longo, M, Soriano, G, Francés, R, Gallego-Durán, R, Herrojo, JA, Tafani, M, Dongiovanni, P, Romero-Gómez, M. SIRT5 rs12216101 T > G variant is associated with hepatic encephalopathy and impaired ammonia metabolism in patients with cirrhosis. JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).

01/05/2026 Rechallenge after a DILI episode: importance of the pattern and the medication class

Fernández-Aguilera, M, Calvo-Orteu, M, Aparicio, AP, Carrión, JA, de Miera, IS, Vergara, M, Poca, M, Canga, E, Ardevol, A, Ariza, X, Amador, A, Sáez-Peñataro, J, Forns, X, Barciela, MR. Rechallenge after a DILI episode: importance of the pattern and the medication class. JOURNAL OF HEPATOLOGY. 2026; 84DOI:. PMID:. IF:33.000(Q1/1D).

01/05/2026 Sex differences in prognosis of oral cavity carcinoma

Gayà, J, Moix, X, Valero, C, Todaro, M, Perquoti, F, Quer, M, León, X. Sex differences in prognosis of oral cavity carcinoma. Acta Otorrinolaringologica Espanola. 2026; 77(3)DOI:10.1016/j.otorri.2026.512326. PMID:. IF:(Q/D).

01/05/2026 Cognitive and behavioral disturbances in PSP and MSA: clinical features and imaging correlates

Ruiz-Barrio, I, Horta-Barba, A, Martinez-Horta, S, Kulisevsky, J, Pagonabarraga, J. Cognitive and behavioral disturbances in PSP and MSA: clinical features and imaging correlates. JOURNAL OF NEURAL TRANSMISSION. 2026; 133(5)DOI:10.1007/s00702-026-03146-8. PMID:42115350. IF:4.000(Q1/2D).

01/05/2026 Investigating Hypo-Egoic Features: Ayahuasca's Psychedelic Path Versus Meditation's Mindful Journey

Arqueros, M, Soler, J, Cebolla, A, Garcia-Campayo, J, Domínguez-Clavé, E, Pascual, JC. Investigating Hypo-Egoic Features: Ayahuasca's Psychedelic Path Versus Meditation's Mindful Journey. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL. 2026; 41(3)DOI:10.1002/hup.70046. PMID:42083787. IF:1.700(Q3/6D).

01/05/2026 Genomic and evolutionary insights into a novel Neisseria meningitidis genogroup W clonal complex 11 variant with dual resistance to penicillin and azithromycin in Spain

Roca-Grande, J, Moreno-Mingorance, A, Alvarez-López, P, Arando, M, Bellés-Bellés, A, Calvo-Montes, J, Càmara, J, Cercenado, E, Descalzo, V, Galán-Ladero, MA, García-Pérez, JN, Gómez, F, Hoyos-Mallecot, Y, López-Madueño, J, Lung, MY, Martín-Nalda, A, Mir-Cros, A, Muñoz-Almagro, C, Cruz, DND, Oliveira-Souto, I, Orellana, MA, Palop, B, Pérez-Argüello, A, Moreno, MOP, Puigsech-Boixeda, G, Quesada, MD, Rivera, A, Rodrigo, C, Rodriguez-Fernandez, A, de Gopegu, ER, Sarvisé, C, Serre-Delcor, N, Soler-Palacín, P, Soler-Garcia, A, Trejo-Zahino, J, Viñado, B, Larrosa, MN, González-López, JJ. Genomic and evolutionary insights into a novel Neisseria meningitidis genogroup W clonal complex 11 variant with dual resistance to penicillin and azithromycin in Spain. Microbial Genomics. 2026; 12(5)DOI:10.1099/mgen.0.001703. PMID:42118576. IF:4.000(Q1/3D).

01/05/2026 Real-World Outcomes of Nebulized Levofloxacin in Chronic Bronchial Infection and Non-Cystic Fibrosis Bronchiectasis: A Comparative Analysis From the Inbreathing Registry

Gonzalez, J, Villar, CS, Calero, C, Erro, M, Alvarado-Miranda, M, Pastor, EL, Baran, E, Esteban, V, Layla, D, Pou, C, Ester, Z, Sánchez, CP, Pomares, X, Montón, C, Urrutia, B, Lores, C, Pitarch, JL, Girón, R, Sayés, A, Urrestarazu, EG, Alcaide, A, Costa, R, Ortola, MV, Santisteve, S, Manzano, C, Monge, A, Benítez, ID, Moncusí-Moix, A, Sánchez-Cucó, A, Morales, A, Castañon, R, Navarro, A, Lakhani, JS, De Torres, J, Suarez-Cuartin, G, de la Rosa, D, Gracia-Lavedan, E, Moreno, BR. Real-World Outcomes of Nebulized Levofloxacin in Chronic Bronchial Infection and Non-Cystic Fibrosis Bronchiectasis: A Comparative Analysis From the Inbreathing Registry. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2026; 212DOI:10.1093/ajrccm/aamag162.1311. PMID:. IF:19.400(Q1/1D).

01/05/2026 Heart Rate Response to Sleep Apnea Events Predicts Long-Term Cardiovascular Risk in Resistant Hypertension: The Sarah Real-World Study

Amezcua, PR, Benitez, I, Puech, C, Escalera, E, Galan, C, Torres, G, Gracia-Lavedan, E, Martínez, D, Minguez, O, Vaca, R, Pascual, L, Aguilá, M, Fernandez, AC, Dalmases, M, Garcia, MM, Mediano, O, Romero, S, Fortuna, AM, Marquez, PP, Drager, LF, Cabrinir, M, Barros, S, Masa, JF, Vazquez, S, Río, FG, Casitas, R, Cano, I, Lee, CH, Barbe, F, de la Torre, MS. Heart Rate Response to Sleep Apnea Events Predicts Long-Term Cardiovascular Risk in Resistant Hypertension: The Sarah Real-World Study. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2026; 212DOI:10.1093/ajrccm/aamag162.1360. PMID:. IF:19.400(Q1/1D).

01/05/2026 Quantitative Computed Tomography Analysis Distinguishes Acute Exacerbation From Progressive Fibrosing Phenotypes in Interstitial Lung Disease

Carranza, MM, Zapata, JO, Montero, IE, Francesqui, J, Cuerpo, S, Benegas, M, Alsina, X, Perez, N, Frino, A, Albacar, N, Osorio, J, Moises, J, Soler, N, Martinez, P, Amaro, R, Hernandez-Gonzalez, F, Sánchez, M, Sellares, J. Quantitative Computed Tomography Analysis Distinguishes Acute Exacerbation From Progressive Fibrosing Phenotypes in Interstitial Lung Disease. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2026; 212DOI:10.1093/ajrccm/aamag162.2444. PMID:. IF:19.400(Q1/1D).

01/05/2026 Honeycombing Predicts Mortality in Acute Exacerbations of Interstitial Lung Disease: A Quantitative Computed Tomography Analysis

Carranza, MM, Zapata, JO, Montero, IE, Francesqui, J, Cuerpo, S, Benegas, M, Alsina, X, Perez, N, Frino, A, Albacar, N, Jeisson, O, Moises, J, Soler, N, Martínez, P, Amaro, R, Hernández-González, F, Sánchez, M, Jacobo, S. Honeycombing Predicts Mortality in Acute Exacerbations of Interstitial Lung Disease: A Quantitative Computed Tomography Analysis. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2026; 212DOI:10.1093/ajrccm/aamag162.2443. PMID:. IF:19.400(Q1/1D).

01/05/2026 Characteristics and Management of Patients With Fibrosing Interstitial Lung Disease in Spain: Data From the Separ- ILD Registry

Valenzuela, C, Aburto, M, Menendez, MH, Rigual, J, Molina-Molina, M, Mulet, A, Sevila, RG, -Jimenez, EC, Torres, JS, Inchausti, M, Sanchez, MN, Acosta, O, Sempere, MS, Roman, FL, Fernandez, AS, Castillo, D, Portal, JR, Besteiro, EM. Characteristics and Management of Patients With Fibrosing Interstitial Lung Disease in Spain: Data From the Separ- ILD Registry. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2026; 212DOI:10.1093/ajrccm/aamag162.2478. PMID:. IF:19.400(Q1/1D).

01/05/2026 Clinical Remission With Beclometasone/formoterol/glycopyrronium in Asthma: Real-world Evidence From the Trimaximize Study

Gessner, C, Trinkmann, F, Bogoevska, V, Russell, RE, Ulrik, CS, Pohl, W, Plaza, V, Bourdin, A, Kupczyk, M, Braido, F, Fritz, C, Hahn, A, Grickschat, V, Lommatzsch, M. Clinical Remission With Beclometasone/formoterol/glycopyrronium in Asthma: Real-world Evidence From the Trimaximize Study. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2026; 212DOI:10.1093/ajrccm/aamag162.568. PMID:. IF:19.400(Q1/1D).

01/05/2026 Evolution of sexually transmitted infections cases in the city of Barcelona (2007-2024): profiles by reporting centre

Pericas, C, Palma, D, Palau, M, Aguirre-Cañas, L, Castell, S, Rius, C, Grau, M, de Andrés, A, Collado-Quífer, L, Forcadell-Díez, L. Evolution of sexually transmitted infections cases in the city of Barcelona (2007-2024): profiles by reporting centre. Gaceta Sanitaria. 2026; 40DOI:10.1016/j.gaceta.2026.102589. PMID:42140062. IF:1.500(Q3/7D).

01/05/2026 Validation of screening criteria for interstitial lung disease in rheumatoid arthritis in routine clinical practice: the VAR-EPIDSER study

Mena-Vázquez, N, Domínguez-Alvaro, M, Hernán, MGB, Atienza-Mateo, B, Peña, MFV, Fernández, IP, Ortiz, AM, Park, HS, Gomez, NP, Plasencia-Rodríguez, C, Hurtado, MCA, Pérez, SH, Serrano-Combarro, A, Vegas-Revenga, N, Vidal, JAB, Lacasa-Molina, J, Burger, S, Fernández, CC, Aresté, JF, Ostiz, JAM, Gómez, MDM, Alvaredo, D, Castañeda, S. Validation of screening criteria for interstitial lung disease in rheumatoid arthritis in routine clinical practice: the VAR-EPIDSER study. RMD Open. 2026; 12(2)DOI:10.1136/rmdopen-2026-006934. PMID:42150840. IF:4.700(Q1/1D).

01/05/2026 Consensus-based validation of key quality indicators in pancreatic cancer surgery in Catalonia: a modified Delphi study

Guarga, L, Sánchez-Velázquez, P, Badia, JM, Ballesteros, M, Esteban, L, Busquets, J, Espín-Alvarez, F, Sánchez-Cabús, S, Ausania, F, Pando, E, Jorba-Martin, R, García-Domingo, MI, Lopez-Ben, S, Escartín, A, Burdio, F, García-Borobia, F, Borras, JM, Manchon-Walsh, P. Consensus-based validation of key quality indicators in pancreatic cancer surgery in Catalonia: a modified Delphi study. CIRUGIA ESPANOLA. 2026; 104(5)DOI:10.1016/j.ciresp.2026.800304. PMID:. IF:1.300(Q3/7D).

01/05/2026 CLINICAL CHARACTERISTICS ASSOCIATED WITH THE DIFFERENT GEOMETRIC PATTERNS OF THE HEART IN HYPERTENSION

Oliveras, A, Armario, P, Fernández-Llama, P, Vazquez, S, Blanch, P, Calero, F, Ramos-Galí, A, Sierra, C, Camps, C, Crespo, M, de la Sierra, A. CLINICAL CHARACTERISTICS ASSOCIATED WITH THE DIFFERENT GEOMETRIC PATTERNS OF THE HEART IN HYPERTENSION. JOURNAL OF HYPERTENSION. 2026; 44(SUPPL 1)DOI:10.1097/01.hjh.0001195976.30797.eb. PMID:. IF:4.100(Q1/3D).

01/05/2026 A survey of practice patterns for patient-specific quality assurance on behalf of the ESTRO dosimetry & quality assurance focus group

Dufreneix, S, Essers, M, Aspradakis, MM, Wegener, S, Saez, J, Ventura, T, Jornet, N, Gerskevitsh, E. A survey of practice patterns for patient-specific quality assurance on behalf of the ESTRO dosimetry & quality assurance focus group. Physics & Imaging In Radiation Oncology. 2026; 39DOI:10.1016/j.phro.2026.100993. PMID:42205230. IF:(Q/D).

01/05/2026 The definition of response and inadequate response to topical corticosteroid treatment in atopic dermatitis and related skin inflammatory diseases: A GA2LEN ADCARE statement paper

Zuberbier, T, Abuzakouk, M, Fischer, IA, Arruda, LK, Augustin, M, Beck, L, Bernstein, J, Bindslev-Jensen, C, Bertolín-Colilla, M, Bangert, C, Calderón-Llosa, O, Canonica, GW, Roldan-Castor, MA, Casis-Hao, RJ, Cherrez-Ojeda, I, Choo, KJL, Chularojanamontri, L, Cork, MJ, Craig, TJ, Criado, PR, Custovic, A, Çetinarslan, T, Çalicioglu, F, de Bruin-Weller, M, Douladiris, N, Ensina, LF, Öztürk, YE, Ertas, R, Ferrucci, SM, Rosario, N, Flohr, C, Fluhr, J, Fomina, D, Gregoriou, S, Gotua, M, Giménez-Arnau, AM, Hoetzenecker, W, Jack, C, Criado, RFJ, Katoh, N, Katoulis, A, Karadag, EIK, Larenas-Linnemann, D, Lee, HY, Lima, H, Mansour, E, Mortz, CG, Felix, MMR, Morris, V, Castro, AM, Bruscky, DMV, Mukhina, O, Nguyen, DV, Nosbaum, A, Ozceker, D, Özkaya, E, Kara, RO, Parisi, CAS, Peter, J, Puig, L, Ramon, GD, Rincón-Pérez, C, Sahiner, UM, Schmid-Grendelmeier, P, Serra-Baldrich, E, Dikicier, BS, Smith, CH, Staubach, P, Stevanovic, K, Kucuk, OS, Mitrevska, NT, Thaci, D, Torres, MJ, Torres, T, Zanetti, MET, Tuchinda, P, Vadasz, Z, Vakirlis, E, Duarte, GV, Virtanen, H, Werfel, T, Wollenberg, A, Worm, M, Yew, YW, Pereira, MP. The definition of response and inadequate response to topical corticosteroid treatment in atopic dermatitis and related skin inflammatory diseases: A GA2LEN ADCARE statement paper. World Allergy Organization Journal. 2026; 19(5)DOI:10.1016/j.waojou.2026.101380. PMID:42028244. IF:4.300(Q2/4D).

01/05/2026 Melanoma Arising in a BAP1-Inactivated Melanocytic Tumor

Peirano, F, Llanos, V, Marghoob, AA. Melanoma Arising in a BAP1-Inactivated Melanocytic Tumor. JAMA Dermatology. 2026; 162(5)DOI:10.1001/jamadermatol.2025.5354. PMID:41848722. IF:11.000(Q1/1D).

01/05/2026 Preclinical validation of VasCraf: a human-derived decellularized and re-endothelialized tissue-engineered vascular graft in a porcine arterial model

Iraola-Picornell, G, Lopez-Puerto, L, Onetti, Y, Arisa, M, Jorge, E, Berastegui, E, Martinez-Falguera, D, Balcells, M, Alvarez-Palomo, B, Savio, A, Castells-Sala, C, Vilarrodona, A, Martorell, J, Munoz-Guijosa, C, Galvez-Monton, C. Preclinical validation of VasCraf: a human-derived decellularized and re-endothelialized tissue-engineered vascular graft in a porcine arterial model. CARDIOVASCULAR RESEARCH. 2026; 122DOI:10.1093/cvr/cvag092.141. PMID:. IF:13.300(Q1/1D).

01/05/2026 Multi-ancestry genome-wide association and integrated multi-omics analyses of endometriosis and its clinical manifestations

Koller, D, He, J, Lokhammer, S, Aranda, S, Qiu, D, Davtian, D, Chen, QY, Xu, Z, Mao, ZZ, Friligkou, E, Karaca, S, Cormand, B, Flores, I, Altmäe, S, Mitjans, M, Cabrera-Mendoza, B, Polimanti, R. Multi-ancestry genome-wide association and integrated multi-omics analyses of endometriosis and its clinical manifestations. NATURE GENETICS. 2026; 58(5)DOI:10.1038/s41588-026-02582-2. PMID:42056605. IF:29.000(Q1/1D).

01/05/2026 Space for women in homelessness: exploratory study from a gender lens

de Puelles, P, Valmayor, S, Roel, E. Space for women in homelessness: exploratory study from a gender lens. Gaceta Sanitaria. 2026; 40DOI:10.1016/j.gaceta.2026.102601. PMID:42119344. IF:1.500(Q3/7D).